✦ LIBER ✦

Advances in radiotherapy for head and neck cancer

✍ Scribed by S.A. Bhide; C.M. Nutting

Book ID: 113833338
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 119 KB
Volume: 46
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2010.03.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperfractionated accelerated radiothera

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

✍ Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB 👁 2 views

## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de

Selective neck dissection in the managem

Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update

✍ Marc Hamoir; C.René Leemans; Gilles Dolivet; Sandra Schmitz; Vincent Grégoire; G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Abstract For patients with advanced regional disease, neck dissection following (chemo)radiotherapy remains controversial. Selective neck dissection (SND) was reported as suitable after chemoradiation in patients with advanced regional disease. Reduced morbidity represents the major advantage of

Hypofractionated radiotherapy for the pa

Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial”

✍ Sandro V. Porceddu; Brenda Rosser; Bryan H. Burmeister; Mark Jones; Brigid Hicke 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Neurotoxicity in a phase I trial of cont

Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer

✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which

Hyperfractionated, accelerated radiother

Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: Quality of life in a prospective phase I/II trial

✍ Jolie Ringash; Gina Lockwood; Brian O’Sullivan; Padraig Warde; Andrew Bayley; Be 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 99 KB

PCN86 COST-EFFECTIVENESS OF CETUXIMAB CO

PCN86 COST-EFFECTIVENESS OF CETUXIMAB COMBINED WITH RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER IN TAIWAN

✍ AL Chan; HW Leung; SJ Lin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB